Clinical Evidence

Regulatory3

• ISO 20916
• NMPA Innovative Medical Device Pathway
• Summary of Safety and Clinical Performance(SSCP)

Quality & Risk1

• Post-Production Information (Risk)

Cybersecurity2

• Medjacking
• MITRE ATT&CK(ATT&CK)

Clinical & Trials48

• Adaptive Trial Design
• Adverse Event(AE)
• ALCOA+
• Analytical Sensitivity
• Bayesian Trial Design
• Blinding and Masking
• Case Report Form(CRF)
• Clinical Evaluation Plan(CEP)
• Clinical Evaluation Report(CER)
• Clinical Investigation Plan(CIP)
• Composite Endpoint
• Data Safety Monitoring Board(DSMB)
• Decentralized Clinical Trial(DCT)
• Early Feasibility Study(EFS)
• Electronic Data Capture(EDC)
• Feasibility Study
• First-in-Human Study(FIH)
• Human Factors Engineering(HFE)
• ICH E6 Good Clinical Practice(GCP)
• IDE Annual Progress Report
• IDE Supplement
• Informed Consent
• Institutional Review Board(IRB)
• Intent-to-Treat vs Per-Protocol(ITT / PP)
• Investigational Device Exemption(IDE)
• Investigator Brochure(IB)
• Investigator-Initiated Trial(IIT)
• Limit of Detection / Limit of Quantitation(LoD / LoQ)
• Lost to Follow-up
• Master Protocol (Basket / Umbrella / Platform)
• Minimal Clinically Important Difference(MCID)
• Non-Inferiority Trial
• Pivotal Trial
• Pragmatic Trial
• Primary and Secondary Endpoints
• Propensity Score Methods
• Protocol Deviation
• Real-World Data(RWD)
• Real-World Evidence(RWE)
• Risk-Based Monitoring(RBM)
• Sample Size and Statistical Power
• Serious Adverse Event(SAE)
• Sham Control
• Source Data Verification(SDV)
• Surrogate Endpoint
• Trial Master File(TMF)
• Unanticipated Adverse Device Effect(UADE)
• Use Error

Standards3

• Essential Performance
• ICH E6(R3) Good Clinical Practice(E6(R3))
• ISO 14155

Software & AI4

• Algorithmic Bias and Fairness
• Clinical Decision Support(CDS)
• Foundation Model (Healthcare)
• Generative AI in Medical Devices

Post-Market1

• Post-Market Clinical Follow-up(PMCF)

Market Segments3

• Clinical Laboratory Improvement Amendments(CLIA)
• Remote Patient Monitoring(RPM)
• Wearables and Remote Patient Monitoring(RPM)

Reimbursement8

• CMS IDE Coverage (Category A & B)
• Coverage with Evidence Development(CED)
• Health Economics and Outcomes Research(HEOR)
• Health Technology Assessment(HTA)
• Joint Clinical Assessment(JCA)
• Proprietary Laboratory Analyses Codes(PLA)
• Protecting Access to Medicare Act(PAMA)
• RWE for Reimbursement

Commercialization3

• Field Clinical Engineer(FCE)
• Good Clinical Practice(GCP)
• Pre-Submission Meeting(Q-Sub)

Industry Bodies1

• Contract Research Organization(CRO)

Other ecosystems